Insulin-like growth factor I (IGF-I) and lipid peroxidation products (LPp:s) in the control of leishmaniasis (1998)
- Autores:
- Autores USP: GOTO, HIRO - FM ; GIDLUND, MAGNUS AKE - FM
- Unidade: FM
- Assuntos: PATOLOGIA; MEDICINA PREVENTIVA
- Idioma: Inglês
- Imprenta:
- Nome do evento: International Congress of Immunology
-
ABNT
GOTO, Hiro et al. Insulin-like growth factor I (IGF-I) and lipid peroxidation products (LPp:s) in the control of leishmaniasis. 1998, Anais.. New Delhi: Monduzzi, 1998. . Acesso em: 18 set. 2024. -
APA
Goto, H., Gomes, C. M. C., Lindoso, J. A. L., & Gidlund, M. A. (1998). Insulin-like growth factor I (IGF-I) and lipid peroxidation products (LPp:s) in the control of leishmaniasis. In . New Delhi: Monduzzi. -
NLM
Goto H, Gomes CMC, Lindoso JAL, Gidlund MA. Insulin-like growth factor I (IGF-I) and lipid peroxidation products (LPp:s) in the control of leishmaniasis. 1998 ;[citado 2024 set. 18 ] -
Vancouver
Goto H, Gomes CMC, Lindoso JAL, Gidlund MA. Insulin-like growth factor I (IGF-I) and lipid peroxidation products (LPp:s) in the control of leishmaniasis. 1998 ;[citado 2024 set. 18 ] - Desempenho do antígeno recombinante proteína do choque térmico HSP 83 de L. infantum na sorologia de Leishmanioses
- Apoptosis and lipid peroxidations in experimental visceral Leishmaniasis
- Insulin like growth factor I(IGF-I) and lipid peroxidation products (LPp:s) in the control of leishmaniasis
- Apoptosis of inflammatory cells in the liver in visceral leishmaniasis in hamsters
- Performance of leishmania heat shock protein (HSP) 83 in the diagnosis of tegumentary leishmaniasis
- Anti-leishmania infantum HSP83 antibodies for the follow up of cutaneous (CL) and mucocutaneous (MCL) leishmaniasis patients
- High density lipoprotein modulated the expression of scavenger receptors on U-937 cells induced by low density lipoprotein and modified low density lipoprotein
- Anti-oxidized LDL antibody level in hamster under anti-retroviral protease inhibitor treatment
- Desenvolvimento de lipodistrofia/dislipidemia em pacientes HIV soropositivos durante 12 meses de acompanhamento após introdução da Haart
- Cardiovascular risk factors, anti-oxidized LDL antibody level and cardiac and renal alterations under anti-retroviral protease inhibitors treatment in hamster
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
